JP2010535722A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535722A5
JP2010535722A5 JP2010519351A JP2010519351A JP2010535722A5 JP 2010535722 A5 JP2010535722 A5 JP 2010535722A5 JP 2010519351 A JP2010519351 A JP 2010519351A JP 2010519351 A JP2010519351 A JP 2010519351A JP 2010535722 A5 JP2010535722 A5 JP 2010535722A5
Authority
JP
Japan
Prior art keywords
alkyl
branched
linear
cycloalkyl
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2010519351A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535722A (ja
Filing date
Publication date
Priority claimed from EP07114019A external-priority patent/EP2022783A1/en
Application filed filed Critical
Publication of JP2010535722A publication Critical patent/JP2010535722A/ja
Publication of JP2010535722A5 publication Critical patent/JP2010535722A5/ja
Ceased legal-status Critical Current

Links

JP2010519351A 2007-08-08 2008-07-17 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体 Ceased JP2010535722A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07114019A EP2022783A1 (en) 2007-08-08 2007-08-08 "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors"
PCT/EP2008/005843 WO2009018909A2 (en) 2007-08-08 2008-07-17 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013212664A Division JP5746298B2 (ja) 2007-08-08 2013-10-10 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体

Publications (2)

Publication Number Publication Date
JP2010535722A JP2010535722A (ja) 2010-11-25
JP2010535722A5 true JP2010535722A5 (esLanguage) 2011-08-25

Family

ID=38754730

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010519351A Ceased JP2010535722A (ja) 2007-08-08 2008-07-17 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体
JP2013212664A Active JP5746298B2 (ja) 2007-08-08 2013-10-10 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体
JP2015094698A Active JP6023846B2 (ja) 2007-08-08 2015-05-07 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013212664A Active JP5746298B2 (ja) 2007-08-08 2013-10-10 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体
JP2015094698A Active JP6023846B2 (ja) 2007-08-08 2015-05-07 ホスホジエステラーゼ阻害剤としての1−フェニル−2−ピリジニルアルキルアルコールの誘導体

Country Status (37)

Country Link
US (7) US7923565B2 (esLanguage)
EP (3) EP2022783A1 (esLanguage)
JP (3) JP2010535722A (esLanguage)
KR (1) KR101200683B1 (esLanguage)
CN (1) CN101796028B (esLanguage)
AR (1) AR068057A1 (esLanguage)
AU (1) AU2008286027B2 (esLanguage)
BR (1) BRPI0814065B8 (esLanguage)
CA (1) CA2695580C (esLanguage)
CL (1) CL2008002330A1 (esLanguage)
CO (1) CO6290760A2 (esLanguage)
CY (2) CY1117324T1 (esLanguage)
DK (2) DK2185515T3 (esLanguage)
EA (1) EA017530B1 (esLanguage)
ES (2) ES2655816T3 (esLanguage)
GE (1) GEP20125537B (esLanguage)
HR (2) HRP20160292T1 (esLanguage)
HU (2) HUE035557T2 (esLanguage)
IL (2) IL203712A (esLanguage)
JO (1) JO3181B1 (esLanguage)
LT (1) LT2947068T (esLanguage)
MA (1) MA31586B1 (esLanguage)
ME (1) ME00974B (esLanguage)
MX (1) MX2010001544A (esLanguage)
MY (1) MY152692A (esLanguage)
NO (1) NO2947068T3 (esLanguage)
NZ (1) NZ583103A (esLanguage)
PE (1) PE20090698A1 (esLanguage)
PL (2) PL2947068T3 (esLanguage)
PT (2) PT2947068T (esLanguage)
RS (2) RS54606B1 (esLanguage)
SI (2) SI2185515T1 (esLanguage)
TN (1) TN2010000044A1 (esLanguage)
TW (1) TWI444366B (esLanguage)
UA (1) UA99622C2 (esLanguage)
WO (1) WO2009018909A2 (esLanguage)
ZA (1) ZA201000832B (esLanguage)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2022783A1 (en) 2007-08-08 2009-02-11 CHIESI FARMACEUTICI S.p.A. "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors"
EP2216327A1 (en) 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors
DK2560611T3 (en) 2010-04-21 2018-02-26 Chiesi Farm Spa Process for providing particles with reduced electrostatic charges
MA34449B1 (fr) 2010-08-03 2013-08-01 Chiesi Farma Spa Formulation de poudre seche comprenant un inhibiteur de phosphodiesterase
CA2807406C (en) * 2010-08-03 2018-12-11 Chiesi Farmaceutici S.P.A. Pharmaceutical formulation comprising a phosphodiesterase inhibitor
KR101886987B1 (ko) 2010-09-30 2018-08-08 키에시 파르마슈티시 엣스. 피. 에이. 흡입용 건조 분말 제제 내 마그네슘 스테아레이트의 용도
PH12013502516A1 (en) * 2011-06-06 2017-08-23 Chiesi Farm Spa Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
CN103827088B (zh) * 2011-09-26 2017-10-13 奇斯药制品公司 作为磷酸二酯酶抑制剂的1‑苯基‑2‑吡啶基烷基醇的衍生物
BR112014009471A2 (pt) 2011-10-21 2017-04-18 Chiesi Farm Spa compostos, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
IN2014DN10239A (esLanguage) 2012-06-04 2015-08-07 Chiesi Farma Spa
CN104822659A (zh) * 2012-12-05 2015-08-05 奇斯药制品公司 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇衍生物
BR112015012949A2 (pt) 2012-12-05 2017-07-11 Chiesi Farm Spa composto, composição farmaceutica, uso de um composto, dispositivo inalatório e kit
BR112015012716A2 (pt) 2012-12-05 2017-07-11 Chiesi Farm Spa derivados de feniletilpiridina como inibidores de pde4
RU2015121043A (ru) 2012-12-05 2017-01-11 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные фенилэтилпиридина в качестве ингибиторов PDE-4
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
KR102240865B1 (ko) 2013-10-22 2021-04-16 키에시 파르마슈티시 엣스. 피. 에이. Pde4 억제제의 제조 방법
HK1225384A1 (zh) 2013-12-05 2017-09-08 奇斯药制品公司 用於治疗呼吸病的二苯甲基衍生物
WO2015082616A1 (en) 2013-12-05 2015-06-11 Chiesi Farmaceutici S.P.A. Heteroaryl derivatives for the treatment of respiratory diseases
WO2015185128A1 (en) * 2014-06-04 2015-12-10 Chiesi Farmaceutici S.P.A. 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)- 2-carbonyloxy)ethyl)pyridine derivatives as pde-4 inhibitors
WO2015185130A1 (en) * 2014-06-04 2015-12-10 Chiesi Farmaceutici S.P.A. 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as pde-4 inhibitors
US9763924B2 (en) * 2014-06-05 2017-09-19 Chiesi Farmaceutici S.P.A. Aminoester derivatives
US9326976B2 (en) 2014-06-05 2016-05-03 Chiesi Farmaceutici S.P.A. Carbamate derivatives
TW201710254A (zh) * 2015-06-01 2017-03-16 吉斯藥品公司 胺基酯衍生物
EP3732164A1 (en) 2017-12-28 2020-11-04 Chiesi Farmaceutici S.p.A. Use of 1-phenyl-2-pyridinyl alkyl alcohol derivatives for treating cystic fibrosis
EP3960457A4 (en) 2019-04-26 2022-05-04 Fuji Corporation DEVICE AND METHOD FOR DETECTING PRESSURE PARAMETERS
US12247674B2 (en) * 2021-01-18 2025-03-11 Chad Heffernan Eclipse valve assembly
WO2023117985A1 (en) 2021-12-21 2023-06-29 Chiesi Farmaceutici S.P.A. Dry powder formulations filled in an inhaler with improved resistance to humidity
WO2023208982A1 (en) 2022-04-27 2023-11-02 Chiesi Farmaceutici S.P.A. Crystal form of a pde4 inhibitor
WO2024027901A1 (en) 2022-08-02 2024-02-08 Chiesi Farmaceutici S.P.A. Predictive biomarker of clinical response to a pde4 inhibitor
CA3267958A1 (en) 2022-09-22 2024-03-28 Chiesi Farmaceutici S.P.A. CAPSULE INHALATOR FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR
CA3268102A1 (en) 2022-09-22 2024-03-28 Chiesi Farmaceutici S.P.A. CAPSULE INHALATOR FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR
JP2025532672A (ja) 2022-09-22 2025-10-01 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ ホスホジエステラーゼ-4阻害剤の投与のためのカプセル吸入器

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124455A (en) 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5935978A (en) * 1991-01-28 1999-08-10 Rhone-Poulenc Rorer Limited Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group
IL106517A0 (en) 1992-07-28 1994-08-26 Rhone Poulenc Rorer Ltd Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic or heteroatom containing linking group
US5786354A (en) 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
GB9412573D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
WO1998012178A1 (en) 1996-09-17 1998-03-26 Merck & Co., Inc. Method of preparing phosphodiesterase iv inhibitors
EP1157007A1 (en) 1999-02-25 2001-11-28 Merck Frosst Canada Inc. Pde iv inhibiting compounds, compositions and methods of treatment
CN1784382A (zh) * 2003-03-12 2006-06-07 细胞基因公司 7-氨基-异吲哚基化合物及其药物用途
CA2520779A1 (en) * 2003-03-31 2004-11-11 Kyowa Hakko Kogyo Co., Ltd. Agent for intra-airway administration
US7888381B2 (en) * 2005-06-14 2011-02-15 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
WO2008006509A1 (en) * 2006-07-14 2008-01-17 Chiesi Farmaceutici S.P.A. Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
EP2022783A1 (en) 2007-08-08 2009-02-11 CHIESI FARMACEUTICI S.p.A. "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors"
EP2070913A1 (en) 2007-12-14 2009-06-17 CHIESI FARMACEUTICI S.p.A. Ester derivatives as phosphodiesterase inhibitors
EP2110375A1 (en) 2008-04-14 2009-10-21 CHIESI FARMACEUTICI S.p.A. Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
EP2216327A1 (en) * 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors
CA2807406C (en) 2010-08-03 2018-12-11 Chiesi Farmaceutici S.P.A. Pharmaceutical formulation comprising a phosphodiesterase inhibitor
MA34449B1 (fr) 2010-08-03 2013-08-01 Chiesi Farma Spa Formulation de poudre seche comprenant un inhibiteur de phosphodiesterase
PH12013502516A1 (en) 2011-06-06 2017-08-23 Chiesi Farm Spa Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
CN103827088B (zh) 2011-09-26 2017-10-13 奇斯药制品公司 作为磷酸二酯酶抑制剂的1‑苯基‑2‑吡啶基烷基醇的衍生物
BR112014009471A2 (pt) 2011-10-21 2017-04-18 Chiesi Farm Spa compostos, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
IN2014DN10239A (esLanguage) 2012-06-04 2015-08-07 Chiesi Farma Spa

Similar Documents

Publication Publication Date Title
JP2010535722A5 (esLanguage)
ATE556058T1 (de) 1-(2h)-isochinolonderivat
JP2015535277A5 (esLanguage)
WO2008115098A3 (fr) 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
WO2005037781A3 (fr) Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
RU2017125025A (ru) Конденсированные кольцевые гетероарильные соединения и их применение в качестве ингибиторов trk
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
JP2006521359A5 (esLanguage)
AR082519A1 (es) Fenilamidinas que tienen alta actividad fungicida, y su utilizacion
JP2014525420A5 (esLanguage)
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
JP2011046700A5 (esLanguage)
JP2007508359A5 (esLanguage)
SE0400284D0 (sv) Novel compounds
JP2014526533A5 (esLanguage)
NO20070445L (no) Pyrimidinderivater.
MX344276B (es) Compuesto de piperidina novedoso o sal del mismo.
WO2008096870A1 (ja) アザ架橋環化合物
EA201270359A1 (ru) Терапевтическое средство от расстройств настроения
JP2006508979A5 (esLanguage)
JP2016500653A5 (esLanguage)
MX2013007938A (es) Compuesto biciclico novedoso o sal del mismo.
RU2019131147A (ru) Новые хиназолиноновые производные, ингибирующие pi3k, и содержащая их фармацевтическая композиция
NO20080033L (no) Kinolinderivater som NK3-antagonister